EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Differentiating Creatine and Phosphocreatine In Vivo Using 3 T 1 H MR Spectroscopy

Ralph E Hurd iD, Meng Gu, Philip M Adamson iD, Kenichi Okamura, Masafumi Shibata, Yoshikazu Ono, Moussa Haidar, Kirk Riemer iD, Frank L Hanley, Daniel M Spielman iD

Magnetic Resonance in Medicine · 2026

DOI: 10.1002/mrm.70171 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Magnetic Resonance in Medicine, 2026. Verfasst von Ralph E Hurd und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Phosphocreatine, Creatine, Proton Magnetic Resonance Spectroscopy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, CLC NIH HHS, Clinical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Validation and improvements to the proton MR spectroscopic measurement of creatine and phosphocreatine in vivo at 3 T.

Methods

Spectral simulations were used to evaluate and explore the mitigation of LCModel fitting bias due to lineshape, signal‐to‐noise (SNR) and non‐metabolite backgrounds with a focus on phosphocreatine and the spline regularization settings in the fitting model.

Results

Although phosphocreatine and creatine are visually unresolved, excellent fitting estimates are achieved in the absence of non‐metabolite background using default settings. However, in the presence of non‐metabolite background, bias is observed and depends on lineshape, SNR and differences in the non‐metabolite background. A more flexible setting for the LCModel spline largely mitigates this bias, allowing for the confidence to use proton MRS for PCr dynamic studies.

Conclusion

Without prior knowledge of the non‐metabolite signal, default settings of LCModel can introduce significant bias. Modified setup for LCModel improves quantitation of phosphocreatine and reduces bias in the overall set of metabolites.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhosphocreatineCreatineProton Magnetic Resonance SpectroscopyHumansSignal-To-Noise RatioAlgorithmsReproducibility of ResultsComputer SimulationMagnetic Resonance SpectroscopyMale

Stichwörter der Autor:innen

MR spectroscopycirculatory arrestcreatinemacromoleculesnon‐metabolitesphosphocreatinesynthetic MRS

Substanzen

PhosphocreatineCreatine

Autor:innen und Institutionen

  • Department of Radiology, Stanford University School of Medicine, Stanford, California, USA.
  • Department of Electrical Engineering, Stanford University School of Medicine, Stanford, California, USA.
  • Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California, USA.

ORCID-Profile: Ralph E Hurd, Philip M Adamson, Kirk Riemer, Daniel M Spielman

Förderung

  • NHLBI NIH HHS
  • CLC NIH HHS
  • Clinical Center

Zitieren

APA

Hurd, R. E., Gu, M., Adamson, P. M., Okamura, K., Shibata, M., Ono, Y., Haidar, M., Riemer, K., Hanley, F. L., & Spielman, D. M. (2026). Differentiating Creatine and Phosphocreatine In Vivo Using 3 T 1 H MR Spectroscopy. Magnetic Resonance in Medicine. https://doi.org/10.1002/mrm.70171

Vancouver

Hurd RE, Gu M, Adamson PM, Okamura K, Shibata M, Ono Y, et al. Differentiating Creatine and Phosphocreatine In Vivo Using 3 T 1 H MR Spectroscopy. Magnetic Resonance in Medicine. 2026. doi:10.1002/mrm.70171

BibTeX
@article{Hurd2026,
  author = {Hurd, Ralph E and Gu, Meng and Adamson, Philip M and Okamura, Kenichi and Shibata, Masafumi and Ono, Yoshikazu and Haidar, Moussa and Riemer, Kirk and Hanley, Frank L and Spielman, Daniel M},
  title = {Differentiating Creatine and Phosphocreatine In Vivo Using 3 T 1 H MR Spectroscopy},
  journal = {Magnetic Resonance in Medicine},
  year = {2026},
  doi = {10.1002/mrm.70171}
}
Kostenlos starten →